1. Home
  2. PETS vs RNXT Comparison

PETS vs RNXT Comparison

Compare PETS & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$1.81

Market Cap

38.0M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.91

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PETS
RNXT
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
37.0M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
PETS
RNXT
Price
$1.81
$0.91
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
205.8K
283.1K
Earning Date
06-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$273,800,000.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$2.98
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$1.57
$0.70
52 Week High
$4.10
$1.45

Technical Indicators

Market Signals
Indicator
PETS
RNXT
Relative Strength Index (RSI) 35.39 51.08
Support Level $1.62 $0.89
Resistance Level $1.87 $1.07
Average True Range (ATR) 0.10 0.06
MACD 0.00 0.00
Stochastic Oscillator 26.19 38.51

Price Performance

Historical Comparison
PETS
RNXT

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: